HomeInsightsStock Comparison

Astonea Labs Ltd vs Bafna Pharmaceuticals Ltd Stock Comparison

Astonea Labs Ltd vs Bafna Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Astonea Labs Ltd is ₹ 141.25 as of 13 Jun 15:30.
  • The P/E Ratio of Astonea Labs Ltd is 0 as of March 2020 .The P/E Ratio of Bafna Pharmaceuticals Ltd is 0 as of March 2020.
  • The Market Cap of Astonea Labs Ltd is ₹ 0 crore as of March 2020 .The Market Cap of Bafna Pharmaceuticals Ltd is ₹ 2.1 crore as of March 2020.
  • The revenue of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Bafna Pharmaceuticals Ltd for the Mar '25 is ₹ 40.09 crore as compare to the Dec '24 revenue of ₹ 33.38 crore. This represent the growth of 20.1%.
  • The ebitda of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Bafna Pharmaceuticals Ltd for the Mar '25 is ₹ 2.35 crore as compare to the Dec '24 ebitda of ₹ 3.24 crore. This represent the decline of -27.47%.
  • The net profit of Astonea Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Bafna Pharmaceuticals Ltd changed from ₹ 6.35 crore to ₹ 1.31 crore over 8 quarters. This represents a CAGR of -54.58% .
  • The Dividend Payout of Astonea Labs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Bafna Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astonea Labs Ltd

  • Astonea Labs Ltd was originally incorporated as 'AHU Laboratories Private Limited', as a private limited company, pursuant to certificate of incorporation dated April 11, 2017.
  • Company changed its name from AHU Laboratories Limited to 'Astonea Labs Private Limited' dated February 26, 2019.
  • Subsequently, the Company converted into 'Astonea Labs Limited', vide fresh Certificate of Incorporation dated January 11, 2024. Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.
  • These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
  • These are used for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.

About Bafna Pharmaceuticals Ltd

  • Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
  • The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
  • Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
  • During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

Astonea Labs Ltd News Hub

News

BSE SME Astonea Labs inches higher on debut

The scrip was listed at Rs 137.45, a premium of 1.81% compared with the initial public off...

Read more

03 Jun 2025 11:01

Bafna Pharmaceuticals Ltd News Hub

News

Bafna Pharmaceuticals to table results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 M...

Read more

21 May 2025 10:24

News

Bafna Pharmaceuticals announces board meeting date

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 Fe...

Read more

28 Jan 2025 17:34

News

Bafna Pharmaceuticals to discuss results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 N...

Read more

04 Nov 2024 18:39

News

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

05 Sep 2024 10:29

News

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

04 Sep 2024 17:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

10 Aug 2024 13:56

SWOT Analysis Of Bafna Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bafna Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of null and Bafna Pharmaceuticals Ltd

Which company has a larger market capitalization, Astonea Labs Ltd or Bafna Pharmaceuticals Ltd?

Market cap of Astonea Labs Ltd is 148 Cr while Market cap of Bafna Pharmaceuticals Ltd is 175 Cr

What are the key factors driving the stock performance of Astonea Labs Ltd and Bafna Pharmaceuticals Ltd?

The stock performance of Astonea Labs Ltd and Bafna Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astonea Labs Ltd and Bafna Pharmaceuticals Ltd?

As of June 14, 2025, the Astonea Labs Ltd stock price is INR ₹141.25. On the other hand, Bafna Pharmaceuticals Ltd stock price is INR ₹74.27.

How do dividend payouts of Astonea Labs Ltd and Bafna Pharmaceuticals Ltd compare?

To compare the dividend payouts of Astonea Labs Ltd and Bafna Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions